It's time for the whole heart. Ventripoint (TSXV: VPT) has redesigned VMS to meet the demands of every market. Preparing to move beyond the Left and Right Ventricle to become the first platform to offer 3D volumes for all cardiac chambers, with accuracy equivalent to MRI.....all from the convenience of 2D Ultrasound.
For those interested in distribution opportunities, please use the Distributor contact form.
Cleveland Clinic says...
“The VMS™ will enable us to better image the hearts of patients at risk for pulmonary hypertension and is a wonderful alternative to MRI."
University of Chicago says...
“I expect that an assessment of RV volume and function using the VMS™ will become part of the routine clinical ultrasound evaluation for patients at risk for PAH.
Hospital for Sick Kids says...
“We found an excellent agreement between both techniques and, based on these findings, decided to introduce the method in our Echocardiography Laboratory.